TSLA
Tesla
-- 403.840 NVDA
NVIDIA
-- 134.290 MSTR
MicroStrategy
-- 289.620 FFIE
Faraday Future Intelligent Electric Inc.
-- 2.4300 PLTR
Palantir
-- 75.630 
Looks bad need a saviour
“Overall, the company experienced a net loss of $5.4 million. In terms of business development, Conduit is focusing on developing clinical assets to address diseases with large patient populations and unmet medical needs. The company plans to leverage its clinical and scientific expertise to facilitate the development of clinical assets through Phase II trials. For future plans, Conduit aims to generate revenue through the commercialization or licensing of its product candidates, with the expectation of incurring additional losses and higher operating expenses as it invests in research and development programs. The company's ability to continue operations is dependent on obtaining additional capital and financing.”
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
86866 : With the promising partnership agreement with AstraZeneca , the funding will surely be coming in anytime . . .